CD274 and non-small cell lung carcinoma: Thirty-six patients had MET+ NSCLC (twenty-three patients with METex14 plus thirteen with MET AMP, cut-off not indicated), the median PD-L1 score was 30, and 76% of the patients were ever smokers.